Haleon (LON:HLN) Stock Price Up 2.7% - Here's What Happened

Key Points

• Haleon shares rose 2.7% to GBX 382.70 in mid-day trading, with volume approximately 9% above the average session level.
• Analyst sentiment is mixed: Haleon has an average “Hold” rating and a consensus price target of GBX 387.80, with recent targets ranging from GBX 315 to GBX 514.
• The company reported quarterly earnings of GBX 8.60 per share, alongside a 14.55% net margin and 9.89% return on equity; analysts expect full-year EPS of GBX 19.50.

Haleon plc (LON:HLN - Get Free Report) shares were up 2.7% during mid-day trading on Thursday. The company traded as high as GBX 383.80 and last traded at GBX 382.70. Approximately 30,236,904 shares changed hands during mid-day trading, an increase of 9% from the average session volume of 27,777,375 shares. The stock had previously closed at GBX 372.60.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on HLN shares. JPMorgan Chase & Co. cut their target price on Haleon from GBX 335 to GBX 315 and set an "underweight" rating for the company in a research report on Thursday, June 25th. Berenberg Bank upped their price target on Haleon from GBX 512 to GBX 514 and gave the company a "buy" rating in a research report on Wednesday, August 5th. Royal Bank Of Canada increased their price objective on Haleon from GBX 370 to GBX 390 and gave the stock a "sector perform" rating in a research note on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft cut their price objective on Haleon from GBX 335 to GBX 320 and set a "sell" rating for the company in a report on Wednesday, September 9th. Finally, Jefferies Financial Group reissued a "buy" rating and set a GBX 400 price objective on shares of Haleon in a report on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Haleon currently has an average rating of "Hold" and a consensus price target of GBX 387.80.

Haleon Stock Performance

The company has a quick ratio of 0.93, a current ratio of 0.69 and a debt-to-equity ratio of 50.38. The stock has a market capitalization of £33.66 billion, a price-to-earnings ratio of 21.14, a price-to-earnings-growth ratio of 1.49 and a beta of 0.24. The stock's 50-day simple moving average is GBX 352.42 and its 200 day simple moving average is GBX 350.99.

Haleon (LON:HLN - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported GBX 8.60 earnings per share for the quarter. Haleon had a net margin of 14.55% and a return on equity of 9.89%. Analysts expect that Haleon plc will post 19.50 earnings per share for the current fiscal year.

About Haleon

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.